Renalytix plc Operating Cash Flow
Renalytix plc (RENXF) reported Operating Cash Flow of -$3.84 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-11-19
- Renalytix plc net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$3.84M.
- Renalytix plc net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$7.83M.
- Renalytix plc net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$4.86M.
- Renalytix plc net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$7.92M.
- Renalytix plc net cash provided by (used in) operating activities for fiscal 2024 was -$30.11M.
- Renalytix plc net cash provided by (used in) operating activities for fiscal 2023 was -$34.09M.
- Renalytix plc net cash provided by (used in) operating activities for fiscal 2022 was -$45.92M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | -$3.84M 10-Q · filed 2024-11-19 | -$11.66M derived: sum of 2 quarters · filed 2024-11-19 | -$16.52M derived: sum of 3 quarters · filed 2024-11-19 | -$24.44M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2024-06-30 | -$7.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$12.69M derived: sum of 2 quarters · filed 2024-09-30 | -$20.61M derived: sum of 3 quarters · filed 2024-09-30 | -$30.11M 10-K · filed 2024-09-30 | |
| 2024-03-31 | -$4.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$12.78M derived: sum of 2 quarters · filed 2024-05-15 | -$22.29M 10-Q · filed 2024-05-15 | -$30.92M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-12-31 | -$7.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$17.42M 10-Q · filed 2024-02-14 | -$26.06M derived: sum of 3 quarters · filed 2024-11-19 | -$36.16M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-09-30 | -$9.50M 10-Q · filed 2024-11-19 | -$18.14M derived: sum of 2 quarters · filed 2024-11-19 | -$28.24M derived: sum of 3 quarters · filed 2024-11-19 | -$36.47M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-06-30 | -$8.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$18.73M derived: sum of 2 quarters · filed 2024-09-30 | -$26.97M derived: sum of 3 quarters · filed 2024-09-30 | -$34.09M 10-K · filed 2024-09-30 | |
| 2023-03-31 | -$10.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$18.33M derived: sum of 2 quarters · filed 2024-05-15 | -$25.45M 10-Q · filed 2024-05-15 | -$39.62M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$8.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$15.35M 10-Q · filed 2024-02-14 | -$29.52M derived: sum of 3 quarters · filed 2024-02-14 | -$36.54M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | -$7.12M 10-Q · filed 2023-11-14 | -$21.29M derived: sum of 2 quarters · filed 2023-11-14 | -$28.31M derived: sum of 3 quarters · filed 2023-11-14 | -$42.55M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$14.17M derived: 10-K 12 month − 6-K 9 month · filed 2023-09-28 | -$21.19M derived: sum of 2 quarters · filed 2023-09-28 | -$35.43M derived: sum of 3 quarters · filed 2023-09-28 | -$45.92M 10-K · filed 2023-09-28 | |
| 2022-03-31 | -$7.02M derived: 6-K 9 month − 6-K 6 month · filed 2023-06-09 | -$21.27M derived: sum of 2 quarters · filed 2023-06-09 | -$31.76M 6-K · filed 2023-06-09 | -$36.85M derived: sum of 4 quarters · filed 2023-06-09 | |
| 2021-12-31 | -$14.24M derived: 6-K 6 month − 6-K 3 month · filed 2023-03-30 | -$24.73M 6-K · filed 2023-03-30 | -$29.83M derived: sum of 3 quarters · filed 2023-03-30 | -$34.56M derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-09-30 | -$10.49M 6-K · filed 2022-11-30 | -$15.59M derived: sum of 2 quarters · filed 2022-11-30 | -$20.31M derived: sum of 3 quarters · filed 2022-11-30 | ||
| 2021-06-30 | -$5.10M derived: 20-F 12 month − 6-K 9 month · filed 2022-10-31 | -$9.82M derived: sum of 2 quarters · filed 2022-10-31 | -$28.40M 20-F · filed 2022-10-31 | ||
| 2021-03-31 | -$4.73M derived: 6-K 9 month − 6-K/A 6 month · filed 2022-06-30 | -$23.30M 6-K · filed 2022-06-30 | |||
| 2020-12-31 | -$18.58M 6-K/A · filed 2022-04-29 | ||||
| 2020-06-30 | -$9.52M 20-F · filed 2022-10-31 | ||||
| 2019-06-30 | -$6.16M 20-F/A · filed 2022-08-01 | ||||
| 2018-06-30 | -$427.00K 20-F/A · filed 2020-11-10 |